Vizsgálati helyszín
Michigan State University Clinical Center
East Lansing, Michigan 48824, Egyesült ÁllamokMég nincs intézményhez kötve
- 3futó vizsgálat
- 15lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 18 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis7 vizsgálat
- 2. fázis6 vizsgálat
- 2/3. fázis1 vizsgálat
- Állapot
- Lezárult15 vizsgálat
- Fut, nem toboroz3 vizsgálat
- Fő szponzor
- National Cancer Institute (NCI)10 vizsgálat
- Children's Oncology Group4 vizsgálat
- Alliance for Clinical Trials in Oncology1 vizsgálat
- ECOG-ACRIN Cancer Research Group1 vizsgálat
- National Heart, Lung, and Blood Institute (NHLBI)1 vizsgálat
- és még 1
Lezárt vizsgálatok
Lezárult
Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer
NCT03382561· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
NCT03213678· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
NCT02828358· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer
NCT02844816· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
The National Myelodysplastic Syndromes (MDS) Study
NCT02775383· National Heart, Lung, and Blood Institute (NHLBI)· Forrás
Lezárult
Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma
NCT01979536· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
NCT01553149· 2. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
NCT01236560· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
NCT00601900· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
NCT00557193· 3. fázis· Children's Oncology Group· Forrás
Lezárult
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
NCT00324805· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
NCT00408005· 3. fázis· National Cancer Institute (NCI)· Forrás
Lezárult
Study of Kidney Tumors in Younger Patients
NCT00898365· Children's Oncology Group· Forrás
Lezárult
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
NCT00082745· Children's Oncology Group· Forrás
Lezárult
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
NCT00904241· Children's Oncology Group· Forrás
Hibát jelzek